Literature DB >> 1525121

The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.

M Cortellaro, C Boschetti, E Cofrancesco, C Zanussi, M Catalano, G de Gaetano, L Gabrielli, B Lombardi, G Specchia, L Tavazzi.   

Abstract

The Progetto Lombardo Atero-Trombosi (PLAT) Study was a prospective, multicenter, multidisciplinary study of the association among hemostatic variables, conventional risk factors, and atherothrombotic events in four groups of patients with preexisting vascular ischemic disease (335 myocardial infarction survivors, 123 patients with stable angina pectoris, 160 with transient ischemic attacks, and 335 with peripheral vascular disease). In the myocardial infarction group, univariate analysis showed that atherothrombotic events were associated with high fibrinogen (p = 0.001), factor VIII:C (p less than 0.001), and von Willebrand factor antigen (vWF:Ag) (p = 0.004) levels and with low high density lipoprotein cholesterol (p = 0.043), factor VII (p = 0.019), and protein C (p = 0.044) levels; multivariate analysis produced associations with high fibrinogen and factor VIII:C levels and low protein C levels. By both univariate and multivariate analysis, events in the angina pectoris group were associated with high vWF:Ag (p = 0.026) and leukocyte (p = 0.033) levels and the presence of carotid arterial stenosis (p = 0.063); associations with high leukocyte (p = 0.037) and factor VIII:C (p = 0.186) levels, family history (p = 0.031), and diabetes (p = 0.061) were also found in the group with transient ischemic attacks. In those with peripheral vascular disease, events were associated with Fontaine stage greater than or equal to IIB (p = 0.024), high factor VIII:C levels (p = 0.073), and low protein C (p = 0.028), fibrinogen (p = 0.030), antithrombin III (p = 0.054), and factor VII (p = 0.057) levels by univariate analysis and with Fontaine stage and low fibrinogen levels by multivariate analysis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525121     DOI: 10.1161/01.atv.12.9.1063

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  15 in total

1.  A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.

Authors:  Kevin R Viel; Deepa K Machiah; Diane M Warren; Manana Khachidze; Alfonso Buil; Karl Fernstrom; Juan C Souto; Juan M Peralta; Todd Smith; John Blangero; Sandra Porter; Stephen T Warren; Jordi Fontcuberta; Jose M Soria; W Dana Flanders; Laura Almasy; Tom E Howard
Journal:  Blood       Date:  2007-01-05       Impact factor: 22.113

2.  Factor VII and incidence of myocardial infarction in a Japanese population: The Jichi Medical School Cohort Study.

Authors:  Takuya Shiraishi; Shizukiyo Ishikawa; Kazuomi Kario; Kazunori Kayaba; Eiji Kajii
Journal:  J Clin Lab Anal       Date:  2017-02-13       Impact factor: 2.352

3.  Association of ACE and FACTOR VII gene variability with the risk of coronary heart disease in north Indian population.

Authors:  R C Sobti; Nishi Maithil; Hitender Thakur; Yashpaul Sharma; K K Talwar
Journal:  Mol Cell Biochem       Date:  2010-04-03       Impact factor: 3.396

4.  Hemostatic Factors and Ischemic Heart Disease Risk Among Postmenopausal Women.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

Review 5.  How it all starts: Initiation of the clotting cascade.

Authors:  Stephanie A Smith; Richard J Travers; James H Morrissey
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-05-28       Impact factor: 8.250

6.  Family history and socioeconomic factors as predictors of myocardial infarction, unstable angina and stroke in an Italian population. PROGETTO 3A Investigators.

Authors:  F Vitullo; R Marchioli; R Di Mascio; L Cavasinni; A D Pasquale; G Tognoni
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

7.  von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction.

Authors:  J H Jansson; T K Nilsson; O Johnson
Journal:  Heart       Date:  1998-10       Impact factor: 5.994

Review 8.  von Willebrand factor and its relevance to cardiovascular disorders.

Authors:  G Y Lip; A D Blann
Journal:  Br Heart J       Date:  1995-12

9.  In vitro and in vivo evaluation of the effect of elevated factor VIII on the thrombogenic process.

Authors:  M Golder; J Mewburn; D Lillicrap
Journal:  Thromb Haemost       Date:  2012-11-22       Impact factor: 5.249

10.  Elevated factor VIII level and stroke in patients without traditional risk factors associated with cardiovascular diseases.

Authors:  Anetta Lasek-Bal; Przemysław Puz; Zofia Kazibutowska
Journal:  Neuropsychiatr Dis Treat       Date:  2013-06-17       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.